scorecardresearch
Add as a preferred source on Google
Wednesday, April 8, 2026
TopicCovid-19 treatment

Topic: Covid-19 treatment

Drug patented in 1960s can halve recovery time in mild & moderate Covid cases, study finds

Citing the findings of a clinical trial involving 200 patients, a team of researchers has urged the Health Ministry to include antiviral drug Indomethacin in the country's Covid treatment protocols.

India’s 1st Covid nasal spray FabiSpray aimed at high-risk adults, doesn’t let virus reach lungs

Designed to kill the coronavirus in the upper airways before it progresses to the lungs, the nitric oxide spray was approved after clinical trials on 306 Covid patients in India.

Why Covid drug Ivermectin remains popular despite warnings & lack of evidence on efficacy

University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug. 

MP’s Satna has many Covid hotspots. But its hospitals are empty as no one trusts doctors

Several villages in Satna district are red zones, or hotspots, but despite having oxygen beds & other resources, the region’s hospitals are empty. 

Self-medication for Covid has turned disastrous. Families must not assume doctors’ role

The collective confusion over Covid-19 treatment has led to a compulsive, panic-driven behaviour among Indians. We must return to the idea of 'under doctor’s supervision'.

As I stand in PPE, many patients say drugs don’t work, give Coronil — the damage Ramdev did

If Baba Ramdev spent a few days, or at least a few hours, at Covid-19 ICU frontlines, he would surely learn to respect modern medicine.

Doctors spot new trend in Covid 2nd wave: Strokes in recovering or discharged patients

Neurologists say they have noticed a higher incidence of patients in recovery suffering ischemic strokes as opposed to last year when Covid-19 first struck.

There’s no unique Andhra Covid strain which is 15 times more virulent, says CCMB chief

CCMB director Rakesh Mishra says prevalence of N440K strain in Andhra Pradesh is less than 5% at the moment and is likely to disappear or be replaced soon.

With 55,512 cases, nearly 500 deaths in a month, Chhattisgarh is India’s latest Covid red flag

Chhattisgarh has, along with Maharashtra and Punjab, emerged as one of the epicentres of the Covid-19 second wave in India. 

Modi govt expert panel green lights clinical trial of tapeworm infection drug to treat Covid

The drug niclosamide was earlier used on patients with SARS during the 2004 outbreak, and is considered a promising option for Covid-19. 

On Camera

Rahul Gandhi wants to jail Himanta Sarma but Congress has a Bihar-sized problem in Assam

The Congress has promised Rs 50,000 assistance to each woman but as we've seen in many recent elections, voters seem to be conscious of the proverb: 'A bird in hand is worth two in the bush.'

Stocks fall, oil prices climb as Trump issues fresh threat to Iran ahead of his deadline

Fears that an escalation of the conflict could heighten a fuel squeeze & endanger the economy unnerved traders, with NYT reporting Iran stopped negotiating a truce with the US.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.